The ACME Laboratories Ltd. announcements
156 Dhaka Stock Exchange announcements for The ACME Laboratories Ltd. (ACMELAB) since 2016: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2016 (17).
- Category Change
The Company will be placed in 'A' category from existing 'N' category with effect from December 14, 2016 as the Company has reported disbursement of 35% cash dividend for the year ended on June 30, 2016.
- Prohibition on providing loan facilities to purchase securities
The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase any security of The ACME Laboratories Ltd. in between 1st to 30th trading day after change of categorization, starting from December 14, 2016 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2016 to the respective shareholders' Bank Accounts through BEFTN system. The dividend warrants whose Bank Accounts are not under BEFTN, have been dispatched through Courier service on December 05, 2016.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.79 for July-September, 2016 as against Tk. 1.43 for July-September, 2015; NOCFPS was Tk. 1.74 for July-September, 2016 as against Tk. 0.93 for July-September, 2015. NAV per share was Tk. 79.12 as of September 30, 2016 and Tk. 77.34 as of September 30, 2015.
- Board Meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2016 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA-" in the long term and "ST-3 " in the short term along with a stable outlook in consideration of its audited financials up to June 30, 2016 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after record date
Trading of the shares of the Company will resume on 16.10.2016 after record date.
- Suspension for record date
Trading of the shares of the Company will remain suspended on record date i.e., 13.10.2016.
- Spot for AGM
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 09.10.2016 to 10.10.2016. Trading of the shares of the Company will remain suspended on record date i.e., 13.10.2016.
- Dividend Declaration
The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2016. Date of AGM: 07.11.2016, Time: 10:30 AM, Venue: PSC Convention Hall, Mirpur-14, Dhaka-1206. Record Date: 13.10.2016. The Company has also reported EPS of Tk. 6.55, NAV per share of Tk. 77.34 and NOCFPS of Tk. 6.25 for the year ended on June 30, 2016 as against Tk. 5.70, Tk. 70.37 and Tk. 6.50 respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (21.09.2016) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on September 20, 2016 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2016.
- Revaluation of Property, Plant and Equipment
The Company has informed that the Board of Directors has approved the revaluation report of the Company's Property, Plant and Equipment except Furniture & Fixtures, Books & Periodicals. Due to revaluation, value of Property, Plant and Equipment as at 30 June 2016 has been increased from Tk. 16,809.53 million to Tk. 17,240.11 million. Revaluation surplus will be accounted for in the Financial Statements for the year ended on June 30, 2016.
- Trading of New Security
Trading of the shares of ACME Laboratories Limited will commence at DSE from today, June 07, 2016 under 'N' category. DSE Trading Code for The ACME Laboratories Limited is "ACMELAB" and DSE Company Code is 18491.
- Prohibition on providing loan
DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested not to provide loan facilities to purchase securities of ACME Laboratories Limited in between 1st to 30th trading day starting from today; June 07, 2016 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.
- Q3
The Company has reported its profit after tax Tk. 249.80 million and basic EPS Tk. 1.55 for the 3(three) months period (January to March 2016) ended on 31 March 2016 as against profit after tax of Tk. 241.87 million and basic EPS of Tk. 1.50 for the same period of the previous year. It is to be noted that basic EPS has been calculated based on weighted average Pre-IPO paid-up number of shares i.e. 161,601,700 shares for both the periods. However, considering Post-IPO 211,601,700 number of shares the CompanyÂs basic EPS for the 3 (three) months period ended on 31 March 2016 would be Tk. 1.18. For the 9 (nine) months (July 2015 to March 2016) period ended on 31 March 2016 profit after tax was Tk. 724.14 million and basic EPS was Tk. 4.48 as against profit after tax of Tk. 656.08 million and basic EPS of Tk. 4.06 for the same period of the previous year. It is to be noted that the said EPS has been calculated based on weighted average Pre-IPO paid-up number of shares i.e. 161,601,700 shares for both the periods. However, considering Post-IPO 211,601,700 number of shares, CompanyÂs basic EPS would be Tk. 3.42 for 9 (nine) months period ended on 31 March 2016 and NAV per share would be Tk. 73.85 as on 31 March 2016.
- Q3
The ACME Laboratories Limited: (Q3): The Company has reported its profit after tax Tk. 249.80 million and basic EPS Tk. 1.55 for the 3(three) months period (January to March 2016) ended on 31 March 2016 as against profit after tax of Tk. 241.87 million and basic EPS of Tk. 1.50 for the same period of the previous year. It is to be noted that basic EPS has been calculated based on weighted average Pre-IPO paid-up number of shares i.e. 161,601,700 shares for both the periods. The ACME Laboratories Limited: (Q3): However, considering Post-IPO 211,601,700 number of shares the CompanyÂs basic EPS for the 3 (three) months period ended on 31 March 2016 would be Tk. 1.18. For the 9 (nine) months (July 2015 to March 2016) period ended on 31 March 2016 profit after tax was Tk. 724.14 million and basic EPS was Tk. 4.48 as against profit after tax of Tk. 656.08 million and basic EPS of Tk. 4.06 for the same period of the previous year. The ACME Laboratories Limited: (Q3): It is to be noted that the said EPS has been calculated based on weighted average Pre-IPO paid-up number of shares i.e. 161,601,700 shares for both the periods. However, considering Post-IPO 211,601,700 number of shares, CompanyÂs basic EPS would be Tk. 3.42 for 9 (nine) months period ended on 31 March 2016 and NAV per share would be Tk. 73.85 as on 31 March 2016.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.